Jazz Pharmaceuticals PLC (JAZZ)
125.10
+5.86
(+4.91%)
USD |
NASDAQ |
Nov 21, 16:00
126.97
+1.87
(+1.49%)
Pre-Market: 08:18
Jazz Pharmaceuticals Enterprise Value: 11.06B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 11.06B |
| November 20, 2024 | 10.70B |
| November 19, 2024 | 10.56B |
| November 18, 2024 | 10.60B |
| November 15, 2024 | 10.85B |
| November 14, 2024 | 11.01B |
| November 13, 2024 | 11.21B |
| November 12, 2024 | 11.22B |
| November 11, 2024 | 11.18B |
| November 08, 2024 | 10.97B |
| November 07, 2024 | 10.69B |
| November 06, 2024 | 10.24B |
| November 05, 2024 | 10.23B |
| November 04, 2024 | 10.11B |
| November 01, 2024 | 10.17B |
| October 31, 2024 | 10.15B |
| October 30, 2024 | 10.33B |
| October 29, 2024 | 10.26B |
| October 28, 2024 | 10.23B |
| October 25, 2024 | 10.12B |
| October 24, 2024 | 10.02B |
| October 23, 2024 | 10.21B |
| October 22, 2024 | 10.33B |
| October 21, 2024 | 10.33B |
| October 18, 2024 | 10.45B |
| Date | Value |
|---|---|
| October 17, 2024 | 10.42B |
| October 16, 2024 | 10.48B |
| October 15, 2024 | 10.58B |
| October 14, 2024 | 10.20B |
| October 11, 2024 | 10.07B |
| October 10, 2024 | 10.01B |
| October 09, 2024 | 9.980B |
| October 08, 2024 | 9.999B |
| October 07, 2024 | 10.05B |
| October 04, 2024 | 10.10B |
| October 03, 2024 | 10.06B |
| October 02, 2024 | 10.12B |
| October 01, 2024 | 10.08B |
| September 30, 2024 | 10.23B |
| September 27, 2024 | 10.58B |
| September 26, 2024 | 10.53B |
| September 25, 2024 | 10.39B |
| September 24, 2024 | 10.46B |
| September 23, 2024 | 10.46B |
| September 20, 2024 | 10.57B |
| September 19, 2024 | 10.60B |
| September 18, 2024 | 10.49B |
| September 17, 2024 | 10.61B |
| September 16, 2024 | 10.49B |
| September 13, 2024 | 10.44B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.455B
Minimum
Mar 23 2020
17.14B
Maximum
Jul 12 2021
11.58B
Average
11.79B
Median
Feb 01 2024
Enterprise Value Benchmarks
| Avadel Pharmaceuticals PLC | 1.058B |
| Alkermes PLC | 3.862B |
| Medtronic PLC | 129.24B |
| Perrigo Co PLC | 6.985B |
| Iterum Therapeutics PLC | 31.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 215.06M |
| Revenue (Quarterly) | 1.055B |
| Total Expenses (Quarterly) | 794.76M |
| EPS Diluted (Quarterly) | 3.42 |
| Gross Profit Margin (Quarterly) | 89.42% |
| Profit Margin (Quarterly) | 20.38% |
| Earnings Yield | 5.68% |
| Operating Earnings Yield | 8.16% |
| Normalized Earnings Yield | 5.874 |